Zacks.com on MSN6d
TSVT Up on Acquisition Agreement With BMY for $286 Million
TSVT gained 5.26% after the company announced a definitive merger agreement with Bristol Myers Squibb BMY. Per the terms of ...
Zacks Investment Research on MSN23h
2seventy bio, Inc. (TSVT) Upgraded to Buy: Here's Why
Inc. (TSVT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the ...
Zacks Investment Research on MSN5d
Biotech Stock Roundup: TSVT Up on BMY Deal, PTGX Up on Data & More
Mergers and acquisitions grabbed the spotlight in the biotech sector once again this week after Bristol Myers Squibb BMY ...
Business Wire6d
Shareholder Alert: The Ademi Firm investigates whether 2seventy bio, Inc. is obtaining a Fair Price for its Public Shareholders
The Ademi Firm is investigating 2seventy bio (Nasdaq: TSVT) for possible breaches of fiduciary duty and other violations of ...
2seventy bio (TSVT) was downgraded to a Hold Rating at Leerink Partners
In a report released today, Daina Graybosch from Leerink Partners downgraded 2seventy bio (TSVT – Research Report) to a Hold, with a price ...
2seventy bio, Inc. (NASDAQ:TSVT) Receives $7.20 Average PT from Brokerages
Shares of 2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) have received a consensus rating of “Hold” from the eight ...
Nasdaq5d
Biotech Stock Roundup: TSVT Up on BMY Deal, PTGX Up on Data & More
The offer represented an 88% premium to TSVT’s closing price of $2.66 on March 7, 2025. BMY and TSVT have an agreement in place, whereby both companies equally share profits and losses related ...